9/2/2021 (Thu) 12:40 ~ 13:40N1-3NFI Seminar venue

What is CBD ? Current problems and issues of the domestic market.

In recent years, the hemp-derived ingredient cannabidiol (CBD) has continued to grow in the healthcare field on an unprecedented scale. It is an ingredient approved as a medical drug (not approved in Japan), including health foods and cosmetics, vapes, bath salts, and some general foods such as gummies, chocolate, soft drinks, and alcoholic beverages. It has been imported in Japan for several years, but due to problems such as the Cannabis Control Law, many companies cannot enter the market considering business risks. We would like to introduce new movements in the future, such as the impact of the Ministry of Health, Labor and Welfare setting out the direction of reviewing the Cannabis Control Law and the raw materials for next-generation CBD.

一般社団法人日本カンナビジオール協会
Toshihiko Ito